See also this year's filing and all EDGAR filings for this company.
PDF Report 0001517681_2023_Propanc_Biopharma_Inc.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001517681, Propanc Biopharma Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 15,030 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 2,023 |
| 3 | remainder_Assets | 64,598 |
| 4 | LiabilitiesCurrent | 3,062,981 |
| 5 | LiabilitiesNoncurrent | 42,319 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 1,706,452 |
| 9 | ResearchAndDevelopmentExpense | 256,052 |
| 10 | remainder_Expenses | -26,611 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | -722,194 |
| 13 | remainder_ComprehensiveNetIncome | -550,995 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 81,651 |
| 1 | Liabilities | 3,105,300 |
| 2 | Expenses | 1,935,893 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | -3,023,649 |
| 5 | NetIncome | -2,658,087 |
| 6 | ComprehensiveNetIncome | -2,933,584 |
| 7 | BaseVar | 3,198,016 |
| 8 | EconomicCapitalRatio | -5.10 |
Edgar->Model Mapping
Feature Distribution
Change over Time
